Clinical Trials Browser

Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Disease Progression, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02766699 2025-06-03

CerebralEDV

Phase 1 Completed

9 enrolled

CNS

Brain Neoplasms, Glioblastoma, Neoplasms, Neoplasms by Site, Recurrence, Disease Progression

NCT04503265 2025-05-01

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Phase 1/2 Recruiting

122 enrolled

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Disease Progression

NCT04436120 2024-12-03

TRANSLATE

Phase NA Terminated

38 enrolled 17 charts

GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Disease Progression

NCT02189343 2019-11-21

Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed-and-Refractory Multiple Myeloma

Phase 1 Completed

16 enrolled

Plasma cell

Disease, Multiple Myeloma, Recurrence, Disease Progression

NCT02586987 2019-11-18

A Study to Assess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid Tumours

Phase 1 Completed

58 enrolled

BreastDermatologicGastrointestinalThoracic

Biliary Tract Neoplasms, Breast Neoplasms, Lung Neoplasms, Melanoma, Colorectal Neoplasms, Disease Progression

NCT03804866 2019-01-15

NGR-hTNF in Combination With an Anthracycline in Platinum-resistant Ovarian Cancer (NGR018)

Phase 2 Completed

14 enrolled

Gynecologic

Neoplasm Metastasis, Ovarian Neoplasms, Disease Progression

NCT01358071 2018-09-27

NGR018

Phase 2 Completed

119 enrolled

Gynecologic

Neoplasm Metastasis, Ovarian Neoplasms, Disease Progression

NCT03150602 2017-05-12

A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy

Phase 4 Unknown

22 enrolled

Lymphoid

Lymphoma, T-Cell, Peripheral, Disease Progression

NCT01110668 2017-02-28

Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

Phase 2 Completed

2 enrolled

GastrointestinalSarcoma

Disease Progression, Gastrointestinal Stromal Tumors

NCT00908232 2015-01-15

SEQUENTIAL

Phase 2 Completed

163 enrolled 11 charts

Plasma cell

Multiple Myeloma, Disease Progression, Bone Marrow Neoplasms

NCT01692262 2014-06-19

PYRUS

Phase 1 Completed

59 enrolled

Genitourinary

Prostatic Neoplasms, Disease Progression

NCT00171925 2012-04-11

Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I

Phase 3 Terminated

143 enrolled 10 charts

Plasma cell

Multiple Myeloma, Disease Progression

Clinical Trials

BOLSTER

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

TATE-PD1

CAPItrue

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

Carolyn-USA

Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL

CerebralEDV

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

TRANSLATE

Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed-and-Refractory Multiple Myeloma

A Study to Assess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid Tumours

NGR-hTNF in Combination With an Anthracycline in Platinum-resistant Ovarian Cancer (NGR018)

NGR018

A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy

Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

SEQUENTIAL

PYRUS

Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I